6 results match your criteria: "S. G. Battista Hospital[Affiliation]"
The challenging management of cardiac involvement in systemic sarcoidosis.
Acta Cardiol
November 2022
Cardiology Unit, S. G. Battista Hospital, Foligno, Italy.
Article Synopsis
- - A 34-year-old man was diagnosed with complete AV block linked to systemic sarcoidosis affecting his heart, identified through an FDG-PET scan despite a normal cardiac MRI.
- - Treatment began with corticosteroids and monitoring with an implantable loop recorder (ILR), which initially showed improvement in his condition.
- - After 8 months, the ILR detected recurring AV block and new issues in heart function, leading to the initiation of infliximab therapy and the implantation of a dual chamber ICD (implantable cardioverter-defibrillator).
A giant isolated right coronary aneurism.
BJR Case Rep
July 2021
Department of Cardiology, S.G.Battista Hospital, Foligno (PG), Italy.
A previously healthy 32-year-old female hailing from Mexico presented to the emergency department with rectorrhagia. Caseating granulomas were detected on histopathological analysis from cecum ulcerative lesions. A purified protein derivative skin test resulted positive.
View Article and Find Full Text PDFPrevalence of congenital muscular dystrophy in Italy: a population study.
Neurology
March 2015
From the Departments of Paediatrics and Neurology (A.G., F.B., G.T., M. Monforte, E.R., M.P., E.M.), Catholic University, Rome; Unit of Neuromuscular and Neurodegenerative Disorders (A.D., G.T., E.B.), Department of Neurosciences, Bambino Gesù Children's Hospital, Rome; Pediatric Neurology and Neuromuscular Disease and Immunology Unit (I.M., M. Mora, L.M.), Istituto Neurologico Besta, Milan; Department of Neurosciences, Psychiatry and Anaesthesiology (S.M.), University of Messina; Neuromuscular Disease Unit (C.B., C.M.), G. Gaslini Institute, Genoa; Department of Neurosciences (E.P.), University of Padua, Italy; Department of Developmental Neuroscience and Molecular Medicine Neuromuscular Unit (G.A., R.B., F.M.S.), Stella Maris Institute, Pisa; Department of Neurological Sciences (F. Magri, G.P.C.), IRCCS Ospedale Maggiore Policlinico, University of Milan; Child Neurology and Psychiatry Unit (A.B.), IRCCS C. Mondino Foundation; Neuromuscular and Rare Diseases Unit (M. Moggio), IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Dino Ferrari Center, Milano; Child Neurology and Psychiatry Unit (A.P.), IRCCS Istituto delle Scienze Neurologiche di Bologna, Bellaria Hospital, Bologna; Cardiomiologia e Genetica Medica (R.P., L.P.), Dipartimento di Medicina Sperimentale Seconda Università di Napoli; Neuromuscular Center (T.M.), S.G. Battista Hospital, University of Turin; Centro Nemo (K.G.), Milan; Neuromuscular Unit (M.V.), Nigrisoli Hospital, Bologna; Section of Medical Genetics (F.G., A.F.), Department of Experimental and Diagnostic Medicine, Ferrara, Italy; and Dubowitz Neuromuscular Centre (F. Muntoni), UCL Institute of Child Health & Great Ormond Street Hospital for Children, London, UK.
Objective: We provide a nationwide population study of patients with congenital muscular dystrophy in Italy.
Methods: Cases were ascertained from the databases in all the tertiary referral centers for pediatric neuromuscular disorders and from all the genetic diagnostic centers in which diagnostic tests for these forms are performed.
Results: The study includes 336 patients with a point prevalence of 0.
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care?
Neuropediatrics
February 2015
Department of Paediatric Neurology, Catholic University, Rome, Italy.
Objective: In the last years, there has been increasing evidence of cardiac involvement in spinal muscular atrophy (SMA). Autonomic dysfunction has been reported in animal models and in several patients with types I and III SMA, these findings raising the question whether heart rate should be routinely investigated in all SMA patients. The aim of our study was to detect possible signs of autonomic dysfunction and, more generally, of cardiac involvement in types II and III SMA.
View Article and Find Full Text PDFMalignant small-bowel neoplasms: spectrum of disease on MR imaging.
Radiol Med
December 2010
Department of Radiology, AUSL 3 Umbria - S.G. Battista Hospital, Foligno, Perugia, Italy.
Malignant neoplasms of the small bowel are among the rarest types of cancer, accounting for only 2% of all gastrointestinal neoplasms. Owing both to the intrinsic difficulty of common radiographic and endoscopic methods in visualising the entire small bowel and the lack of typical physical findings, a delay in diagnosis is common. Recently, magnetic resonance (MR) imaging has become a widely accepted imaging modality in the study of suspected small-bowel neoplasms due to its ability to depict, without exposure to ionising radiation and with excellent soft-tissue contrast, intraluminal disorders in conjunction with mural, extraparietal and regional abnormalities.
View Article and Find Full Text PDFMechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment.
Stroke
January 2006
Neuroscience Department, S.G. Battista Hospital, University of Turin, Italy.
Background And Purpose: To report results of mechanical disruption or retrieval of thrombus as first-line treatment in patients with stroke attributable to occlusion of the basilar artery, in particular regarding efficiency and safety.
Methods: In 12 consecutive patients with acute stroke attributable to basilar occlusion, mechanical disruption or thrombus retrieval using various loop-shaped tools was tried before eventually starting local intra-arterial thrombolysis with recombinant tissue plasminogen activator (r-tPA). Main inclusion criteria were: National Institutes of Health Stroke Scale score >8 or Glasgow Coma Scale score <12; onset or worsening of symptoms <8 hours; no hemorrhages or large hypodensities on computed tomography scan; and occlusion of the basilar artery matching clinical symptoms.